Glucotrack (GCTK) Cash & Equivalents Growth (1y) (2011 - 2025)
Glucotrack (GCTK) Cash & Equivalents Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -23.33% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 21.89% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 78.03% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 29.00% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 19.45% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 21.40% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.94% |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | 31.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.44% |
| Mar 31, 2025 | 507.88% |
| Dec 31, 2024 | 25.04% |
| Sep 30, 2024 | -94.98% |
| Jun 30, 2024 | -98.19% |
| Mar 31, 2024 | 49.25% |
| Dec 31, 2023 | 94.29% |
| Sep 30, 2023 | 112.53% |
| Jun 30, 2023 | 127.66% |
| Mar 31, 2023 | -79.06% |
| Dec 31, 2022 | -61.86% |
| Sep 30, 2022 | -53.70% |
| Jun 30, 2022 | -51.17% |
| Mar 31, 2022 | -46.11% |
| Dec 31, 2021 | -38.29% |
| Sep 30, 2021 | -34.62% |
| Jun 30, 2021 | -31.45% |
| Mar 31, 2021 | -28.46% |
| Dec 31, 2020 | 2,244.39% |
| Sep 30, 2020 | 775.96% |